Robuta

https://www.techtransfer.nih.gov/patent/e-028-2018-1-hk-08 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS | Technology Transfer receptor antagonists heterocyclic technology transfer https://www.techtransfer.nih.gov/patent/e-213-2015-0-us-05 TRIAZOLE DERIVATIVES AS P2Y14 RECEPTOR ANTAGONISTS | Technology Transfer triazole derivatives receptor antagonists technology transfer https://www.niddk.nih.gov/research-funding/technology-advancement-transfer/research-materials-licensing/heterocyclic-p2y14-antagonists Heterocyclic P2Y14 Antagonists for the Treatment of Various Conditions - NIDDK Composition of highly selective P2Y14 receptor antagonists, as potential therapeutics for asthma, chronic pain, inflammation and diabetes and neurodegeneration. for the heterocyclic antagonists treatment various https://www.techtransfer.nih.gov/patent/e-028-2018-1-ca-03 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS | Technology Transfer receptor antagonists heterocyclic technology transfer https://www.techtransfer.nih.gov/patent/e-051-2021-0-us-02 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS | Technology Transfer receptor antagonists heterocyclic technology transfer https://www.techtransfer.nih.gov/patent/e-213-2015-0-gb-08 TRIAZOLE DERIVATIVES AS P2Y14 RECEPTOR ANTAGONISTS | Technology Transfer triazole derivatives receptor antagonists technology transfer https://www.techtransfer.nih.gov/patent/e-144-2019-0-us-01 Treatment And Prevention Of Neuropathic Pain With P2Y14 Antagonists | Technology Transfer treatment and prevention neuropathic pain